After verifying the efficacy of knockdown (Fig. 2, A and B), we first analyzed the cell proliferation, and knockdown of MUC16 inhibited the proliferation of NPC cells (Fig. 2C). The gene discussed is MUC16; the disease is nasopharyngeal carcinoma.